Literature DB >> 29774305

Multi-slice MRI reveals heterogeneity in disease distribution along the length of muscle in Duchenne muscular dystrophy.

Stephen M Chrzanowski1, Celine Baligand1, Rebecca J Willcocks2, Jasjit Deol2, Ilona Schmalfuss3, Donovan J Lott2, Michael J Daniels4, Claudia Senesac2, Glenn A Walter1, Krista Vandenborne2.   

Abstract

BACKGROUND: Duchenne muscular dystrophy (DMD) causes progressive pathologic changes to muscle secondary to a cascade of inflammation, lipid deposition, and fibrosis. Clinically, this manifests as progressive weakness, functional loss, and premature mortality. Though insult to whole muscle groups is well established, less is known about the relationship between intramuscular pathology and function.
OBJECTIVE: Differences of intramuscular heterogeneity across muscle length were assessed using an ordinal MRI grading scale in lower leg muscles of boys with DMD and correlated to patient's functional status.
METHODS: Cross sectional T1 weighted MRI images with fat suppression were obtained from ambulatory boys with DMD. Six muscles (tibialis anterior, extensor digitorum longus, peroneus, soleus, medial and lateral gastrocnemii) were graded using an ordinal grading scale over 5 slice sections along the lower leg length. The scores from each slice were combined and results were compared to global motor function and age.
RESULTS: Statistically greater differences of involvement were observed at the proximal ends of muscle compared to the midbellies. Multi-slice assessment correlated significantly to age and the Vignos functional scale, whereas single-slice assessment correlated to the Vignos functional scale only. Lastly, differential disease involvement of whole muscle groups and intramuscular heterogeneity were observed amongst similar age subjects.
CONCLUSION: A multi-slice ordinal MRI grading scale revealed that muscles are not uniformly affected, with more advanced disease visible near the tendons in a primarily ambulatory population with DMD. A geographically comprehensive evaluation of the heterogeneously affected muscle in boys with DMD may more accurately assess disease involvement.

Entities:  

Keywords:  Duchenne Muscular Dystrophy; magnetic resonance imaging; myotendinous junction

Mesh:

Year:  2017        PMID: 29774305      PMCID: PMC5953226     

Source DB:  PubMed          Journal:  Acta Myol        ISSN: 1128-2460


  45 in total

1.  Measurement of the functional status of patients with different types of muscular dystrophy.

Authors:  Yi-Jing Lue; Rong-Fong Lin; Shun-Sheng Chen; Yen-Mou Lu
Journal:  Kaohsiung J Med Sci       Date:  2009-06       Impact factor: 2.744

2.  Muscle MRI in Duchenne muscular dystrophy: Evidence of a distinctive pattern.

Authors:  Kiran Polavarapu; Mahadevappa Manjunath; Veeramani Preethish-Kumar; Deepha Sekar; Seena Vengalil; PriyaTreesa Thomas; Talakad N Sathyaprabha; Rose Dawn Bharath; Atchayaram Nalini
Journal:  Neuromuscul Disord       Date:  2016-09-05       Impact factor: 4.296

3.  Strain distribution on rat medial gastrocnemius (MG) during passive stretch.

Authors:  H van Bavel; M R Drost; J D Wielders; J M Huyghe; A Huson; J D Janssen
Journal:  J Biomech       Date:  1996-08       Impact factor: 2.712

Review 4.  Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

Review 5.  Duchenne and Becker muscular dystrophies.

Authors:  Kevin M Flanigan
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

6.  Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression.

Authors:  R J Willcocks; I A Arpan; S C Forbes; D J Lott; C R Senesac; E Senesac; J Deol; W T Triplett; C Baligand; M J Daniels; H L Sweeney; G A Walter; K Vandenborne
Journal:  Neuromuscul Disord       Date:  2014-01-11       Impact factor: 4.296

7.  Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy.

Authors:  Doris G Leung; John A Carrino; Kathryn R Wagner; Michael A Jacobs
Journal:  Muscle Nerve       Date:  2015-03-31       Impact factor: 3.852

8.  Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.

Authors:  Barbara H Janssen; Nicoline B M Voet; Christine I Nabuurs; Hermien E Kan; Jacky W J de Rooy; Alexander C Geurts; George W Padberg; Baziel G M van Engelen; Arend Heerschap
Journal:  PLoS One       Date:  2014-01-14       Impact factor: 3.240

9.  Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes.

Authors:  Marika Pane; Elena Stacy Mazzone; Serena Sivo; Maria Pia Sormani; Sonia Messina; Adele D'Amico; Adelina Carlesi; Gianluca Vita; Lavinia Fanelli; Angela Berardinelli; Yvan Torrente; Valentina Lanzillotta; Emanuela Viggiano; Paola D Ambrosio; Filippo Cavallaro; Silvia Frosini; Andrea Barp; Serena Bonfiglio; Roberta Scalise; Roberto De Sanctis; Enrica Rolle; Alessandra Graziano; Francesca Magri; Concetta Palermo; Francesca Rossi; Maria Alice Donati; Michele Sacchini; Maria Teresa Arnoldi; Giovanni Baranello; Tiziana Mongini; Antonella Pini; Roberta Battini; Elena Pegoraro; Stefano Previtali; Claudio Bruno; Luisa Politano; Giacomo P Comi; Enrico Bertini; Eugenio Mercuri
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

10.  Mechanical function of dystrophin in muscle cells.

Authors:  C Pasternak; S Wong; E L Elson
Journal:  J Cell Biol       Date:  1995-02       Impact factor: 10.539

View more
  11 in total

Review 1.  Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2019-05-14       Impact factor: 3.217

2.  Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort.

Authors:  Sean C Forbes; Harneet Arora; Rebecca J Willcocks; William T Triplett; William D Rooney; Alison M Barnard; Umar Alabasi; Dah-Jyuu Wang; Donovan J Lott; Claudia R Senesac; Ann T Harrington; Erika L Finanger; Gihan I Tennekoon; John Brandsema; Michael J Daniels; H Lee Sweeney; Glenn A Walter; Krista Vandenborne
Journal:  Radiology       Date:  2020-04-14       Impact factor: 11.105

3.  Regional variation of thigh muscle fat infiltration in patients with neuromuscular diseases compared to healthy controls.

Authors:  Tobias Greve; Egon Burian; Agnes Zoffl; Georg Feuerriegel; Sarah Schlaeger; Michael Dieckmeyer; Nico Sollmann; Elisabeth Klupp; Dominik Weidlich; Stephanie Inhuber; Maximilian Löffler; Federica Montagnese; Marcus Deschauer; Benedikt Schoser; Sarah Bublitz; Claus Zimmer; Dimitrios C Karampinos; Jan S Kirschke; Thomas Baum
Journal:  Quant Imaging Med Surg       Date:  2021-06

4.  Postcontractile blood oxygenation level-dependent (BOLD) response in Duchenne muscular dystrophy.

Authors:  Christopher Lopez; Tanja Taivassalo; Maria G Berru; Andres Saavedra; Hannah C Rasmussen; Abhinandan Batra; Harneet Arora; Alex M Roetzheim; Glenn A Walter; Krista Vandenborne; Sean C Forbes
Journal:  J Appl Physiol (1985)       Date:  2021-05-20

5.  Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.

Authors:  Claudia Nuñez-Peralta; Jorge Alonso-Pérez; Jaume Llauger; Sonia Segovia; Paula Montesinos; Izaskun Belmonte; Irene Pedrosa; Elena Montiel; Alicia Alonso-Jiménez; Javier Sánchez-González; Antonio Martínez-Noguera; Isabel Illa; Jordi Díaz-Manera
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-03-04       Impact factor: 12.910

6.  MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne muscular dystrophy.

Authors:  Karin J Naarding; Harmen Reyngoudt; Erik W van Zwet; Melissa T Hooijmans; Cuixia Tian; Irina Rybalsky; Karen C Shellenbarger; Julien Le Louër; Brenda L Wong; Pierre G Carlier; Hermien E Kan; Erik H Niks
Journal:  Neurology       Date:  2020-01-14       Impact factor: 9.910

7.  Semi-Automatic MRI Muscle Volumetry to Diagnose and Monitor Hereditary and Acquired Polyneuropathies.

Authors:  Friederike S Bähr; Burkhard Gess; Madlaine Müller; Sandro Romanzetti; Michael Gadermayr; Christiane Kuhl; Sven Nebelung; Jörg B Schulz; Maike F Dohrn
Journal:  Brain Sci       Date:  2021-02-06

Review 8.  Overview of MR Image Segmentation Strategies in Neuromuscular Disorders.

Authors:  Augustin C Ogier; Marc-Adrien Hostin; Marc-Emmanuel Bellemare; David Bendahan
Journal:  Front Neurol       Date:  2021-03-25       Impact factor: 4.003

9.  Cholesterol absorption blocker ezetimibe prevents muscle wasting in severe dysferlin-deficient and mdx mice.

Authors:  Zoe White; Marine Theret; Nadia Milad; Lin Wei Tung; William Wei-Han Chen; Martin G Sirois; Fabio Rossi; Pascal Bernatchez
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-12-19       Impact factor: 12.910

10.  Selection Approach to Identify the Optimal Biomarker Using Quantitative Muscle MRI and Functional Assessments in Becker Muscular Dystrophy.

Authors:  Nienke M van de Velde; Melissa T Hooijmans; Aashley S D Sardjoe Mishre; Kevin R Keene; Zaïda Koeks; Thom T J Veeger; Iris Alleman; Erik W van Zwet; Jan-Willem M Beenakker; Jan J G M Verschuuren; Hermien E Kan; Erik H Niks
Journal:  Neurology       Date:  2021-06-23       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.